Pancreatic Cancer

The MD Anderson Solid Tumor Oncology series presents the most cutting-edge surgical treatment and medical therapy for specific sites. Each year, more than 26,000 people are diagnosed with pancreatic cancer, also called a 'silent' disease because it does not usually exhibit early symptoms. This volume defines the current standard on multimodality care: surgery, chemotherapy, immunotherapy, gene therapy, radiotherapy, and a review of the latest research and clinical trials.
It includes sections on: epidemiology/molecular biology, inherited pancreatic cancer syndromes, staging, various surgical techniques and outcomes, multimodality therapy and emerging and future therapies. The individual chapters focus on specific topics to produce a reference work of value to those interested in pancreatic cancer from a clinical and translational research perspective. A must-have for surgical oncologists and general surgeons.